A. V. Bedekar et al. / Tetrahedron: Asymmetry 13 (2002) 721–727
725
7.37 (m, 3H), 6.94–7.03 (m, 1H), 4.60 (s, 2H), 3.33 (s,
2H), 2.53–2.73 (m, 2H), 2.30–2.46 (m, 2H), 1.61–1.95
(m, 2H), 1.37 (s, 3H); 13C NMR (75 MHz, CDCl3) l
16.5, 23.3, 32.1, 37.7, 39.0, 49.4, 64.9, 127.6, 128.9,
130.1, 130.3, 131.1, 131.3, 211.9. IR (CHCl3) 3030,
3015, 2960, 1725, 1693, 1605, 1230, 1215, 780 cm−1; MS
(m/z) 310, 308, 293, 267, 265, 246.
Compound 3: Mp 185–186°C (from AcOEt/hexane);
white crystals; [h]1D8 −6.14 (c 0.53, CHCl3, >99% e.e.);
1H NMR (200 MHz, CDCl3) l 7.90–8.10 (m, 4H),
7.04–7.60 (m, 10H), 6.94–7.04 (m, 2H), 3.52 (d, 2H,
J=21.5 Hz), 3.19 (dd, 2H, J=33.0, 15.0 Hz), 1.90 (s,
3H), 1.88 (s, 3H), 1.15 (s, 3H); IR (CHCl3) 3020, 1741,
1708, 1592, 1280, 1220 cm−1; MS (m/z) 549 (M++1),
530, 507, 463, 435, 391, 307, 154. Anal. calcd for
C34H29O5P: C, 74.44; H, 5.33. Found: C, 74.06; H,
5.13%.
Compound 17: Mp 99–100°C; colorless prisms (from
1
AcOEt/hexane); H NMR (200 MHz, CDCl3) l 7.89–
7.74 (m, 4H), 7.21 (m, 1H), 7.02–6.97 (m, 3H), 4.68 (s,
2H), 3.38 (s, 2H), 1.48 (s, 3H); IR (CHCl3) 3020, 1740,
1710, 1598, 1378, 1258 cm−1. Anal. calcd for
C18H15BrO2: C, 62.99; H, 4.40. Found: C, 63.36; H,
4.30%.
1
Compound 4: Mp 215–216°C (from Et2O/hexane); H
NMR (200 MHz, CDCl3) l 6.90–8.15 (m, 16H), 3.51–
3.61 (d, 2H, J=20.8 Hz), 3.16 (dd, 2H, J=24.6, 14.3
Hz), 2.42–2.60 (m, 2H), 2.16–2.36 (m, 2H), 1.45–1.83
(m, 2H), 0.97 (s, 3H); IR (CHCl3) 3060, 3015, 1721,
1692, 1621, 1590, 1511, 1465, 1280, 1221 cm−1; MS
(m/z) 561 (M++1), 560 (M+), 544, 532, 517, 286, 268
(100%), 239, 55. Anal. calcd for C35H29O5P (560): C,
74.99; H, 5.18. Found; C, 74.79; H, 5.10%.
Compound 18: Mp 93–94°C; colorless prisms (from
1
AcOEt/hexane); H NMR (200 MHz, CDCl3) l 7.87–
7.72 (m, 4H), 7.20 (brd, 1H, J=6.5 Hz), 7.04–6.93 (m,
3H), 4.67 (s, 2H), 3.35 (s, 2H), 2.08 (q, 2H, J=7.4 Hz),
0.78 (t, 3H, J=7.6 Hz); IR (CHCl3) 3010, 1740, 1705,
1595, 1462, 1360, 1255 cm−1. Anal. calcd for
C19H17BrO2: C, 63.88; H, 4.80. Found: C, 64.08; H,
4.77%.
Compound 5: Amorphous; [h]1D8 +317 (c 2.2, CHCl3,
>99% e.e.); H NMR (200 MHz, CDCl3) l 8.14–6.89
(m, 20H), 3.60 (d, 2H, J=20.6 Hz), 3.09 (dd, 3H,
J=48.8, 14.4 Hz), 1.05 (s, 3H); IR (CHCl3) 3020, 1741,
1708, 1592, 1280, 1220 cm−1; MS (m/z) 594 (M+);
HRMS (m/z) calcd for C38H27O5P (M+) 594.1596.
Found: 594.1573.
1
4.3. Synthesis of phosphonates 3–7
A solution of (S)-(−)-1,1%-bi-2-naphthol (750 mg, 2.60
mmol) and diisopropylethylamine (740 mg, 5.70 mmol,
2.2 equiv.) in CH2Cl2 (30 mL) was stirred at 0°C for 15
min and dichloromethylphosphite (380 mg, 2.90 mmol,
1.2 equiv.) was added. The mixture was stirred for 1.5
h at room temperature, and concentrated at ambient
temperature to afford crude 14, which was used in the
next reaction without purification.
Compound 6: Amorphous; [h]1D8 +223 (c 1.4, CHCl3,
1
>99% e.e.); H NMR (200 MHz, CDCl3) l 8.16–6.84
(m, 20H), 3.60 (dd, 2H, J=19.9, 5.94 Hz), 3.02 (dd, 3H,
J=49.1, 14.3 Hz), 1.50 (m, 2H), 0.45 (t, 3H, J=7.5
Hz); IR (CHCl3) 3015, 1740, 1706, 1621, 1592, 1230
cm−1; MS (m/z) 608 (M+); HRMS (m/z) calcd for
C39H29O5P (M+) 608.1752. Found: 608.1744.
A mixture of crude 14, 19 (1.20 g, 3.30 mmol, 1.3
equiv.), hydroquinone (10.0 mg) and dichlorobenzene
(2.0 mL) was heated at 160°C under an argon atmo-
sphere with stirring for 24 h. The reaction mixture was
diluted with CH2Cl2 (70 mL) and the resulting solution
was washed with water and brine and then dried.
Evaporation under reduced pressure gave the oily
residue, which was subjected to column chromatogra-
phy on silica gel with hexane/EtOAc (1/1). Compound
7 was obtained as an amorphous solid (660 mg, 41%).
The absence of racemization was confirmed by the
HPLC analysis of the sample obtained in this way.
4.4. Asymmetric cyclization to afford 20–24
The preparation of compounds 20–24 was carried out
by the cyclization described in Table 1. A representative
example is as follows: a solution of 7 (768 mg, 1.23
mmol) and 18-crown-6 (70.1 mg, 0.27 mmol, 0.2 equiv.)
in THF (18 mL) was treated with KDA (6.2 mL, 0.24
M in THF, 1.48 mmol, 1.2 equiv.) at −78°C under
argon and the resulting mixture was stirred for 24 h at
the same temperature. The mixture was quenched by
addition of a sat. NH4Cl solution and extracted with
EtOAc. The organic extract was washed with water and
brine, and then evaporated. The residue was purified by
preparative TLC (hexane/EtOAc, 5/1) to give 24 (18.3
mg, 64%). The sample was analyzed by HPLC on a
chiral stationary phase.
Compound 7: amorphous; [h]1D8 +235.0 (c 1.30, CHCl3,
1
>99% e.e.); H NMR (200 MHz, CDCl3) l 8.17–6.80
(m, 20H), 3.69 (dd, 1H, J=45.7, 15.4 Hz), 3.59 (dd, 1H,
J=48.4, 15.3 Hz), 3.05 (dd, 2H, J=42.8, 14.3 Hz), 1.73
(m, 1H), 0.54 (t, 6H, J=6.5 Hz); IR (CHCl3) 3015,
1738, 1730, 1592, 1509, 1228 cm−1; MS (m/z) 622 (M+);
HRMS (m/z) calcd for C40H31O5P (M+) 622.1909.
Found: 622.1901.
Compound 24: Mp 64°C; colorless needle (from Et2O);
1
[h]1D6 +184 (c 0.44, CHCl3, >99% e.e.); H NMR (200
MHz, CDCl3) l 7.81 (m, 2H), 7.68 (brt, 1H, J=7.6
Hz), 7.44 (brt, 1H, J=7.1 Hz), 7.24 (m, 4H), 7.00 (s,
1H), 3.34 (d, 1H, J=15.8 Hz), 2.80 (d, 1H, J=15.8
Hz), 1.95 (m, 1H), 1.01 (d, 3H, J=7.0 Hz), 0.54 (d, 3H,
J=7.0 Hz); IR (CHCl3) 3015, 2965, 1703, 1600, 1470,
1215 cm−1. Anal. calcd for C20H18O: C, 87.59; H, 6.57.
Found: C, 87.57; H, 6.79%.
Compounds 3, 4, 5 and 6 were afforded from 15, 16, 17
and 18, respectively, without racemization via treat-
ment with 14 in a similar manner to that described
above for the preparation of 7.